# Selected publications for Dr. Jin Linchun
# Full list contains 152+ entries

- year: 2025
  publications:
    - title: "Blocking immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response"
      authors: "H Tao, D Chen, C Yang, DT Nguyen, G Abboud, R Liu, T Liu, [...], L Jin"
      journal: "The Journal of Clinical Investigation"
      citations: 2
      doi: null
      topic: "CAR-T"

    - title: "In Situ Ferroptosis with Global Dynamics Visualization for Glioblastoma Theranostics"
      authors: "R Mungur, P Han, J Gu, K Zhang, X Zhang, M Chatoo, Y Liu, R Shi, H He, [...], L Jin"
      journal: "Journal of Medicinal Chemistry"
      citations: null
      doi: null
      topic: "Glioblastoma"

    - title: "Chimeric lactate receptor engineered t cells"
      authors: "L Deleyrolle, D Mitchell, J Huang, L Jin"
      journal: "US Patent App. 18/842,078"
      citations: null
      doi: null
      topic: "CAR-T"

- year: 2024
  publications:
    - title: "CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia"
      authors: "JA Ligon, P Castillo, X Ma, L Jin, H Tao, D Nguyen, G Jobin, O Guryanova, [...]"
      journal: "Transplantation and Cellular Therapy 30 (2), S178-S179"
      citations: 1
      doi: null
      topic: "CAR-T"

    - title: "IMMU-21. OVEREXPRESSING CAR T-CELL GLUCOSE TRANSPORTER TO ENHANCE ANTI-TUMOR ACTIVITY IN GLIOBLASTOMA"
      authors: "S Sengupta, L Jin, D Feier, A Silver, A Chakraborty, H Tao, N Thomas, [...]"
      journal: "Neuro-Oncology 26 (Suppl 8), viii156"
      citations: null
      doi: null
      topic: "CAR-T"

- year: 2023
  publications:
    - title: "Multimodal in vivo tracking of chimeric antigen receptor T cells in preclinical glioblastoma models"
      authors: "WE Wu, E Chang, L Jin, S Liu, CH Huang, R Kamal, T Liang, NM Aissaoui, [...]"
      journal: "Investigative Radiology 58 (6), 388-395"
      citations: 18
      doi: null
      topic: "CAR-T"

    - title: "Chimeric antigen receptor t-cells expressing interleukin-8 receptor"
      authors: "J Huang, L Jin"
      journal: "US Patent 11,788,093"
      citations: null
      doi: null
      topic: "CAR-T"

    - title: "Bioconjugated liquid-like solid enhances characterization of solid tumor-chimeric antigen receptor T cell interactions"
      authors: "DT Nguyen, R Liu, E Ogando-Rivas, A Pepe, D Pedro, S Qdaisat, [...], L Jin"
      journal: "Acta Biomaterialia 172, 466-479"
      citations: 11
      doi: null
      topic: "CAR-T"

- year: 2022
  publications:
    - title: "CAR T cell locomotion in solid tumor microenvironment"
      authors: "DT Nguyen, E Ogando-Rivas, R Liu, T Wang, J Rubin, L Jin, H Tao, [...]"
      journal: "Cells 11 (12), 1974"
      citations: 44
      doi: null
      topic: "CAR-T"

- year: 2021
  publications:
    - title: "Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance"
      authors: "W Wu, JL Klockow, M Zhang, F Lafortune, E Chang, L Jin, Y Wu, [...]"
      journal: "Pharmacological Research 171, 105780"
      citations: 604
      doi: null
      topic: "Glioblastoma"

    - title: "Optimizing T cell-based therapy for glioblastoma"
      authors: "A Karachi, F Dastmalchi, S Nazarian, J Huang, EJ Sayour, L Jin, C Yang, [...]"
      journal: "Frontiers in Immunology 12, 705580"
      citations: 16
      doi: null
      topic: "Cancer Immunology"

- year: 2020
  publications:
    - title: "Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma"
      authors: "Y Long, H Tao, A Karachi, AJ Grippin, L Jin, Y Chang, W Zhang, [...]"
      journal: "Cancer Research 80 (3), 499-509"
      citations: 106
      doi: null
      topic: "Glioblastoma"

- year: 2019
  publications:
    - title: "CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors"
      authors: "L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, [...]"
      journal: "Nature Communications 10 (1), 4016"
      citations: 320
      doi: null
      topic: "CAR-T"

- year: 2018
  publications:
    - title: "CD70, a novel target of CAR T-cell therapy for gliomas"
      authors: "L Jin, H Ge, Y Long, C Yang, Y Chang, L Mu, EJ Sayour, G De Leon, [...]"
      journal: "Neuro-Oncology 20 (1), 55-65"
      citations: 209
      doi: null
      topic: "CAR-T"

    - title: "The IDH1 mutation-induced oncometabolite, 2-hydroxyglutarate, may affect DNA methylation and expression of PD-L1 in gliomas"
      authors: "L Mu, Y Long, C Yang, L Jin, H Tao, H Ge, YE Chang, A Karachi, [...]"
      journal: "Frontiers in Molecular Neuroscience 11, 82"
      citations: 93
      doi: null
      topic: "Glioblastoma"

    - title: "CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma"
      authors: "YP Park, L Jin, KB Bennett, D Wang, KM Fredenburg, JE Tseng, LJ Chang, [...]"
      journal: "Oral Oncology 78, 145-150"
      citations: 65
      doi: null
      topic: "CAR-T"

- year: 2017
  publications:
    - title: "Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM"
      authors: "H Ge, L Mu, L Jin, C Yang, Y Chang, Y Long, G DeLeon, L Deleyrolle, [...]"
      journal: "International Journal of Cancer 141 (7), 1434-1444"
      citations: 88
      doi: null
      topic: "Glioblastoma"

    - title: "CD4+ and perivascular Foxp3+ T cells in glioma correlate with angiogenesis and tumor progression"
      authors: "L Mu, C Yang, Q Gao, Y Long, H Ge, G DeLeon, L Jin, Y Chang, [...]"
      journal: "Frontiers in Immunology 8, 1451"
      citations: 57
      doi: null
      topic: "Cancer Immunology"

# Note: This is a representative sample. The complete list of 152+ publications
# can be added following the same YAML structure.
#
# To add more publications, follow this format:
# - title: "Publication title"
#   authors: "Author list"
#   journal: "Journal name, volume, pages"
#   citations: number or null
#   doi: "DOI string" or null
#   topic: "Research area (CAR-T, Glioblastoma, Cancer Immunology, etc.)"

